Scientific paper - Original scientific paper
Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development

Kosmac, Kate; Bantug, Glenn R.; Pernjak-Pugel, Ester; Cekinović, Đurđica; Jonjić, Stipan; Britt, William J. (2013)
Cite this document...

Kosmac, K., Bantug, G. R., Pernjak Pugel, E., Cekinović, ., Jonjić, S. & Britt, W. J. (2013). Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development. PLoS Pathogens, 9. (3). doi: 10.1371/journal.ppat.1003200

Kosmac, Kate, et al. "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development." PLoS Pathogens, vol. 9, no. 3, 2013. https://doi.org/10.1371/journal.ppat.1003200

Kosmac, Kate, Glenn R. Bantug, Ester Pernjak Pugel, Đurđica Cekinović, Stipan Jonjić and William J. Britt. "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development." PLoS Pathogens 9, no. 3 (2013). https://doi.org/10.1371/journal.ppat.1003200

Kosmac, K., et al. (2013) 'Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development', PLoS Pathogens, 9(3). doi: 10.1371/journal.ppat.1003200

Kosmac K, Bantug GR, Pernjak Pugel E, Cekinović , Jonjić S, Britt WJ. Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development. PLoS Pathogens [Internet]. 2013 March 07 [cited 2019 August 21];9(3). doi: 10.1371/journal.ppat.1003200

K. Kosmac, G. R. Bantug, E. Pernjak Pugel, . Cekinović, S. Jonjić and W. J. Britt, "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development", PLoS Pathogens, vol. 9, no. 3, March 2013. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:792777. [Accessed: 21 August 2019]